M&A In the Time of COVID-19: Is It the Right Time to Sell?
Sell-side activity has recently rebounded since the start of the pandemic, but is now the right time to sell? Here are four factors clients should consider.
Members on the Move
New hires and relocation news from Vistra, NPL, Fidelity Investments and more.
Gensler Sworn in as SEC Chief | Middle-Market Public Policy Roundup
Gensler is sworn in to lead the SEC, a former PE investor appointed to the Treasury's new climate post, and the federal government offers cash to investors mitigating climate change.
Adapt Your Supply Chain to New Realities
From climate change and de-globalization to shifting demographics and technological advancement, a review of supply chain strategy is necessary.
Sun Capital’s Patient-Centered Approach to Health Care Investing
On the podcast, two investors discuss what Sun Capital looks for in health care deals and how technology can improve the patient experience.
MMG Growth Engine Award Winner: Clearwave
With the help of private equity partner Frontier Growth, health care software provider Clearwave developed a strategy that helped boost organic growth and M&A.
Gensler Approved to Lead SEC Following Senate Vote | Middle-Market Public Policy Roundup
The SEC will have a new leader, an SEC official issues SPAC warning, and a lawmaker publishes thoughts on private equity's role in health care.
The Risks of Underestimating D&O Coverage
While antitrust actions may be associated most commonly with large corporations, mid-sized companies must also be aware of antitrust risk.
Apara Delivers Therapies for Growing Autism Community
While autism therapies and services are consolidating around large and regional actors, they require a different perspective on growth.
Investors See Rebound One Year Into Pandemic
On the anniversary of coronavirus' arrival in the U.S., some portfolio companies are struggling to keep up with the pace of recovery, while others are laying in wait.
